
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
PRP-Z2 columns enable high-resolution oligonucleotide separation with robust performance, reduced salt use, and scalability for research and regulated workflows.





